Skip to main content
Premium Trial:

Request an Annual Quote

Varian to Sell Proxeon Nano-LC System with its Mass Spec

This article has been corrected to note that the agreement is non-exclusive.
NEW YORK (GenomeWeb News) – The Danish proteomics company Proxeon said today it has entered into an agreement with Varian, under which the Proxeon Easy-nLC nanoscale liquid chromatography system will be available for sale by Varian as an interface for one of its mass spectrometers.
Under the non-exclusive, worldwide OEM agreement, the Proxeon nano-LC system will be marketed and sold as the Varian 216-LC, which will interface with the Varian 920-MS Triple Quadrupole Fourier Transform Mass Spectrometer.
Financial terms of the agreement were not released.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.